Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Asymchem Laboratories Tianjin (6821 HK)
Watchlist
49
Analysis
Health Care
•
China
Asymchem Laboratories (Tianjin) Co., Ltd. operates as a pharmaceutical company. The Company researches, produces, and sells organic and inorganic chemicals, medicines, and other related products. Asymchem Laboratories serves customers worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Quantitative Analysis
•
03 Feb 2023 08:00
Hong Kong Connect Flows Monthly: Health Care Led Inflows in Jan
We analyzed the Hong Kong Connect Scheme for January and highlight flows for China Mobile, BYD, Simcere, ICBC, CNOOC, Meituan, Geely, CCB, Country...
Ke Yan, CFA, FRM
Follow
418 Views
Share
bullish
•
Asymchem Laboratories Tianjin
•
20 Jan 2023 09:49
Hong Kong CEO & Director Dealings (20 Jan): Asymchem Labs, Honbridge, Flat Glass, Gushengtang
The data in this insight is collated from the "shareholding disclosure" link on the HKEx website. These insights also flag those companies where...
David Blennerhassett
Follow
439 Views
Share
bullish
•
Quantitative Analysis
•
05 Dec 2022 08:30
A-H Premium Weekly (Dec 2nd): China Longyuan, Ganfeng Lithium
We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Longyuan, Ganfeng Lithium, Shanghai Fudan, Red Star...
Ke Yan, CFA, FRM
Follow
302 Views
Share
bearish
•
Quantitative Analysis
•
06 Nov 2022 14:03
A-H Premium Weekly (Nov 4th): First Tractor, Maanshan Iron
We analyzed A-H premium changes in the past week and highlight A-H premium changes for First Tractor, Maanshan Iron, Datang Intl, Cansino, Jushi,...
Ke Yan, CFA, FRM
Follow
201 Views
Share
bearish
•
Wuxi Biologics
•
11 Oct 2022 08:39
Wuxi Biologics (2269.HK) - Removed from UVL, but the Crisis Is Not Over
Removal from UVL won’t bring fundamental change.The logic of CXO(low labor cost+booming US pharmaceutical IPO) is untenable.We provide trading...
Xinyao (Criss) Wang
Follow
282 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.1
x